BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35700939)

  • 1. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy.
    Dey AD; Bigham A; Esmaeili Y; Ashrafizadeh M; Moghaddam FD; Tan SC; Yousefiasl S; Sharma S; Maleki A; Rabiee N; Kumar AP; Thakur VK; Orive G; Sharifi E; Kumar A; Makvandi P
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):396-419. PubMed ID: 35700939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.
    Cheng Y; Wang J; Rao T; He X; Xu T
    Front Biosci; 2008 Jan; 13():1447-71. PubMed ID: 17981642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimer-based nanocarriers: a versatile platform for drug delivery.
    Hsu HJ; Bugno J; Lee SR; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27126551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new era of nanotechnology, an alternative to change cancer treatment.
    Jurj A; Braicu C; Pop LA; Tomuleasa C; Gherman CD; Berindan-Neagoe I
    Drug Des Devel Ther; 2017; 11():2871-2890. PubMed ID: 29033548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Nanotechnology-An Excursion on Drug Delivery Systems.
    Sharma M; Pandey C; Sharma N; Kamal MA; Sayeed U; Akhtar S
    Anticancer Agents Med Chem; 2018; 18(15):2078-2092. PubMed ID: 30033877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
    Bharali DJ; Khalil M; Gurbuz M; Simone TM; Mousa SA
    Int J Nanomedicine; 2009; 4():1-7. PubMed ID: 19421366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimer nanoparticles for colorectal cancer applications.
    Carvalho MR; Reis RL; Oliveira JM
    J Mater Chem B; 2020 Feb; 8(6):1128-1138. PubMed ID: 31971528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
    Kapalatiya H; Madav Y; Tambe VS; Wairkar S
    Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery.
    Huynh L; Neale C; Pomès R; Allen C
    Nanomedicine; 2012 Jan; 8(1):20-36. PubMed ID: 21669300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.